Verition Fund Management
BIOC

Verition Fund Management’s Biocept, Inc. BIOC Stock Holding History

Verition Fund Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3
Closed -$215K – 531
2014
Q4 		$215K Hold
3
– – 0.05% 225
2014
Q3 		$230K Hold
3
– – 0.03% 511
2014
Q2 		$498K Hold
3
– – 0.05% 260
2014
Q1 		$591K Buy
+3
New +$678K 0.09% 150

Other funds holding BIOC

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $223M AUM 17.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management's BIOC Position: Q1 2015 in Review

Verition Fund Management sold out of Biocept, Inc. (BIOC) in Q1 2015, closing a stake of 3 shares — an estimated $215K sold.

Verition Fund Management first reported a position in BIOC in Q1 2014 and held it in 4 quarters. The position peaked at $591K in Q1 2014. 12 funds tracked by Wall St. Rank hold BIOC as of Q1 2015.

  • Verition Fund Management reported no remaining Biocept, Inc. position as of Q1 2015 after selling out during the quarter.
  • Verition Fund Management sold 3 Biocept, Inc. shares in Q1 2015, an estimated $215K.
  • Verition Fund Management first reported a position in Biocept, Inc. in Q1 2014 and held it in 4 quarters.
  • Verition Fund Management's Biocept, Inc. position peaked at $591K in Q1 2014.
  • 12 funds tracked by Wall St. Rank held Biocept, Inc. as of Q1 2015.

Based on Verition Fund Management's 13F filing for Q1 2015, filed 15 May 2015.